Physician profile
Louis Rivera
NPI 1407904592
$4,884.92
in general payments reported to CMS, 2019-2025
23 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $3,058 · 2021: $416 · 2022: $48.41 · 2023: $47.27 · 2024: $154 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,152.66 | 2019-2021 | |
| Mentor Worldwide LLC | $90.35 | 2025 | Artoura Breast Tissue Expander |
| Blueprint Medicines Corporation | $69.97 | 2020-2025 | Ayvakit |
| Endomagnetics LTD | $63.16 | 2024 | Magtrace, Magseed |
| Beigene USA, INC. | $54.85 | 2021-2025 | Tevimbra, Brukinsa |
| Dova Pharmaceuticals | $41.83 | 2020-2021 | |
| Sobi, INC | $41.24 | 2024 | |
| Tersera Therapeutics LLC | $36.81 | 2025 | Zoladex |
| Ethicon US, LLC | $28.28 | 2025 | |
| Karyopharm Therapeutics INC. | $26.66 | 2023 | Xpovio |
| Springworks Therapeutics, INC. | $25.59 | 2025 | Ogsiveo |
| Novartis Pharmaceuticals Corporation | $25.49 | 2024 | |
| Rigel Pharmaceuticals, INC. | $24.82 | 2022 | |
| Amgen INC. | $24.42 | 2021 | |
| Servier Pharmaceuticals LLC | $24.06 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $23.59 | 2022 | |
| Puma Biotechnology, INC. | $20.68 | 2021 | |
| Accord Healthcare, INC. | $20.61 | 2023 | |
| Genzyme Corporation | $20.46 | 2021 | |
| Janssen Biotech, INC. | $18.89 | 2021 | |
| Checkpoint Surgical, INC | $18.45 | 2019 | |
| Merck Sharp & Dohme LLC | $17.44 | 2020 | |
| Stryker Corporation | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.